Skip to main content
Find more clinical trials

Home-Based Music Therapy for Mild Cognitive Impairment and Alzheimer's Disease

Start: July 25, 2019
End: January 31, 2024
Enrollment: 100

What Is This Study About?

Listening to music or singing songs may provide emotional and behavioral benefits for people with dementia. In this one-year study, researchers will evaluate the effects of home-based music therapy for people with mild cognitive impairment or Alzheimer's disease. If assigned to the treatment group, participants and their study partner will be asked to sing songs at home for at least one hour each day. In addition, some participants will meet with a music therapist several times over a six-month period. Every three months, the researchers will gather information from participants to track changes on cognitive function and quality of life. Screening and participation in this study can be completed in-person or remotely from home.

Do I Qualify To Participate in This Study?

Minimum Age: 55 Years

Maximum Age: N/A

Must have:

  • Diagnosis of Alzheimer's disease or mild cognitive impairment
  • Availability of a study partner to join music therapy sessions
  • English speaking
  • No verbal impairment
  • Must have computer with a video camera or smart phone

Must NOT have:

  • Diagnosis of dementia other than Alzheimer's disease
  • Diagnosis of probable Alzheimer's disease with Down syndrome
  • History of a clinically significant stroke with lasting effects on cognition
  • Current evidence or history in past two years of epilepsy, focal brain lesion, or head injury
  • Current diagnosis for a major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse
  • Conditions causing disability that would interfere with study intervention such as pain or life expectancy less than one year
  • Living in a nursing facility or other dementia care center
  • Current participation in another research study

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 
Study Contact
Juliana Gamino, BFA
John Mondanaro, PhD, LCAT, MT-BC

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

New York
Louis Armstrong Center for Music and Medicine, Mount Sinai Beth Israel
New York, NY 10003
Recruiting
John Mondanaro, PhD, LCAT, MT-BC
Alzheimer's Disease Research Center, Icahn School of Medicine at Mount Sinai
New York, NY 10029
Recruiting
Juliana Gamino, BFA

Who Sponsors This Study?

Lead: Icahn School of Medicine at Mount Sinai

Source: ClinicalTrials.gov ID: NCT04666077